CD47 and cancer: Values of CD47 knockdown efficiency were above 90% in HepG2, and the higher the knockdown of CD47 in cancer cells, the higher the percentage of apoptosis. However, unlike small‐GO‐PEG‐PAMAM/CD47_siRNA, CRT levels were not correlated with cancer apoptosis.